Hyposalivation and the Human Oral Microbiome
Hyposalivation and the Human Oral Microbiome
批准号:
8878218
负责人:
DAVID A. RELMAN
金额:
$57.57万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-01 至 2016-06-30
关键词:
AccountingAcidsAcuteAddressAdolescentAdultAnti-CholinergicsAutoimmune DiseasesAutoimmune ProcessBase SequenceCandidaCanis familiarisChildChronicClassificationCommunitiesCommunity HealthDataDatabasesDental cariesDevelopmentDiagnosisDiagnosticDiseaseEarly DiagnosisFunctional disorderHealthHumanIncidenceIncisorIndividualMeasuresMonitorOralOrganismPatientsPharmaceutical PreparationsPlant RootsPlayPopulationPrognostic MarkerQuality of lifeRadiation therapyRecombinant DNARoleSalivarySalivary GlandsSamplingScopolamineSeriesSiteStructureSucroseSurfaceSyndromeTaxonTherapeuticTherapeutic InterventionTimeTooth LossTooth structureVariantXerostomiabaseclinical practicecohortexperiencehigh riskmalignant oropharynx neoplasmmicrobial communitymicrobiomenovelnovel diagnosticsoral microbiomepatient populationpreventpyrosequencingresilienceresponserestorationspatiotemporalstatisticstooth surface
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hyposalivation, or an abnormally low salivary flow rate, is a major health problem associated with coronal and root surface dental caries, and a profound reduction in quality of life despite best clinical practices. Medications are the most common cause of chronic hyposalivation. A second major cause of chronic hyposalivation is Sj�gren's Syndrome, one of the most prevalent autoimmune disorders in the developed world. The microbiota of the exposed tooth surface plays a critical role in caries formation. In order to reduce the burden of caries and tooth loss in these populations, we propose to identify shifts in the composition of the microbiota that are associated with the acute and chronic states of hyposalivation and the subsequent development of caries. Detection of early diagnostic changes in the microbiota will facilitate early therapeutic intervention. Although many culture-based studies have examined the impact of hyposalivation on oral microbial communities, none have examined spatially explicit impacts at distinct supragingival sites over time. Furthermore, cultivation provides a limited view of bacterial diversity and community structure. Our preliminary, sequencing-based data show that the taxonomic composition of supragingival plaques varies between and across teeth in the absence of hyposalivation. This finding, combined with the observation that the distribution of caries shifts in a site-specific manner to the incisors and canines in states of hyposalivation, suggests that we need to examine spatiotemporal variation in supragingival communities in the absence and presence of hyposalivation if we are to understand (and ultimately prevent) the progression from health- associated to hyposalivation- and caries-associated community states. This Application addresses this need by defining and characterizing population-level transitions and differences in supragingival microbial communities at multiple spatial and temporal scales in health and in acute and chronic states of hyposalivation. Aim 1: Characterize the spatiotemporal dynamics of the supragingival and salivary microbiota in healthy adults in the absence of hyposalivation. Aim 2: Characterize acute impacts of medication-induced hyposalivation on the supragingival and salivary microbiota of healthy adults. Aim 3: Evaluate impact of chronic hyposalivation on the supragingival and salivary microbiota in patients with Sj�gren's Syndrome. Our long-term objectives are to develop new diagnostic markers for hyposalivation-associated cariogenic microbial communities, as well as to develop novel ecologically-based therapeutics to decrease dental caries incidence in high risk patients, and to understand better the role of microbial communities in cariogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Household transmission of the human gut microbiota after antibiotic exposure
-
批准号:10593834
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2022
-
负责人:DAVID A. RELMAN
-
依托单位:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
-
批准号:10624323
-
项目类别:
-
资助金额:$71.51万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
-
批准号:10176389
-
项目类别:
-
资助金额:$72.61万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Microbial dispersal, skin-to-skin contact, and assembly of the neonatal gut microbiome
-
批准号:10178070
-
项目类别:
-
资助金额:$11.83万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
-
批准号:10404963
-
项目类别:
-
资助金额:$72.05万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Environmental Arsenic Exposure, Microbiome, and Human Health
-
批准号:8889677
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Environmental Arsenic Exposure, Microbiome, and Human Health
-
批准号:8606066
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Environmental Arsenic Exposure, Microbiome, and Human Health
-
批准号:9113017
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Integration of Microbe and Host Data Diagnosis of Febrile Illness
-
批准号:9241962
-
项目类别:
-
资助金额:$108.16万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:8579781
-
项目类别:
-
资助金额:$65.74万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:9052450
-
项目类别:
-
资助金额:$19.83万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:8672626
-
项目类别:
-
资助金额:$63.35万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Antibiotics and Human Microbial Community Dynamics
-
批准号:8412747
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2012
-
负责人:DAVID A. RELMAN
-
依托单位:
Antibiotics and Human Microbial Community Dynamics
-
批准号:8975217
-
项目类别:
-
资助金额:$27.65万
-
财政年份:2012
-
负责人:DAVID A. RELMAN
-
依托单位:
Transcriptional profiles of the host response to dengue fever
-
批准号:8260250
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2011
-
负责人:DAVID A. RELMAN
-
依托单位:
Transcriptional profiles of the host response to dengue fever
-
批准号:7675064
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2009
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7571520
-
项目类别:
-
资助金额:$55.85万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7940507
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7691405
-
项目类别:
-
资助金额:$47.66万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7893813
-
项目类别:
-
资助金额:$58.49万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: